Arnault Tauziède-Espariat

Arnault Tauziède-Espariat

Auto-generated profile, based on publicly available information

Arnault Tauziède-Espariat

Department of Neuropathology, GHU Paris - Psychiatry and Neuroscience, Sainte-Anne Hospital, Paris, France

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 May 2017 in Brain Pathology
Verified
Journal Article
Closed access
PDF file
ATArnault Tauziede‐Espariat
Arnault Tauziede‐Espariat
BPBéatrice Parfait
Béatrice Parfait
ABAurore Besnard
Aurore Besnard
JLJoëlle Lacombe
Joëlle Lacombe
JPJohan Pallud
Johan Pallud
PVPascale Varlet
Pascale Varlet

4 January 2016 in Journal of Neuropathology & Experimental Neurology
Verified
Journal Article
Open access
PDF file
ATArnault Tauziède-Espariat
Arnault Tauziède-Espariat
DBDamien Bresson
Damien Bresson
MPMarc Polivka
Marc Polivka
SBSchahrazed Bouazza
Schahrazed Bouazza
FLFrançois Labrousse
François Labrousse
HAHoma Adle-Biassette
Homa Adle-Biassette
Chordomas are slow-growing malignant neoplasms. Determination of histopathologic prognostic factors using a large cohort study has been limited by their low incidence. In this retrospective study, we investigated the clinical, histopathologic, and immunohistochemical prognostic factors in 287 chordomas from 111 patients assessed by central pathologic review. Expression patterns of a variety of markers, including vascular endothelial growth factor (VEGF), mTOR pathway, c-kit, HER2, epidermal growth factor receptor (EGFR) and STAT3, and KRAS , BRAF, EGFR , and PIK3CA mutations were analyzed. On univariate analysis, the results confirm surgery as the best treatment, as judged by patient progression-free survival (PFS) and overall survival (OS). Proton therapy, the presence of a dedifferentiated component, mitotic figures, and Ki67 and p53 labeling indices correlated with PFS. Necrosis and apoptosis correlated with OS. Based on these findings, we propose a histopathologic grading system that correlates with PFS and OS. On multivariate analysis, extent of resection, tumor grade, and proton therapy were independent prognostic factors of PFS; extent of resection, tumor location, and grade were independent prognostic factors of OS. Based on the expression of EGFR, pSTAT3, VEGF, and mTOR pathway proteins, (in 85.9%, 79.1%, 85.7%, and 46% of chordomas, respectively), and 2 new mutations in the PIK3CA gene, we also provide evidence for potential therapeutic targets.

13 August 2021 in Acta Neuropathologica Communications
Verified
Journal Article
Open access
PDF file
ATArnault Tauziède-Espariat
Arnault Tauziède-Espariat
ASAurore Siegfried
Aurore Siegfried
YNYvan Nicaise
Yvan Nicaise
TKThomas Kergrohen
Thomas Kergrohen
PSPhilipp Sievers
Philipp Sievers
PVPascale Varlet
Pascale Varlet
The cIMPACT-NOW Update 7 has replaced the WHO nosology of “ependymoma, RELA fusion positive” by “Supratentorial-ependymoma, C11orf95-fusion positive”. This modification reinforces the idea that supratentorial-ependymomas exhibiting fusion that implicates the C11orf95 (now called ZFTA) gene with or without the RELA gene, represent the same histomolecular entity. A hot off the press molecular study has identified distinct clusters of the DNA methylation class of ZFTA fusion-positive tumors. Interestingly, clusters 2 and 4 comprised tumors of different morphologies, with various ZFTA fusions without involvement of RELA. In this paper, we present a detailed series of thirteen cases of non-RELA ZFTA-fused supratentorial tumors with extensive clinical, radiological, histopathological, immunohistochemical, genetic and epigenetic (DNA methylation profiling) characterization. Contrary to the age of onset and MRI aspects similar to RELA fusion-positive EPN, we noted significant histopathological heterogeneity (pleomorphic xanthoastrocytoma-like, astroblastoma-like, ependymoma-like, and even sarcoma-like patterns) in this cohort. Immunophenotypically, these NFκB immunonegative tumors expressed GFAP variably, but EMA constantly and L1CAM frequently. Different gene partners were fused with ZFTA: NCOA1/2, MAML2 and for the first time MN1. These tumors had epigenetic homologies within the DNA methylation class of ependymomas-RELA and were classified as satellite clusters 2 and 4. Cluster 2 (n = 9) corresponded to tumors with classic ependymal histological features (n = 4) but also had astroblastic features (n = 5). Various types of ZFTA fusions were associated with cluster 2, but as in the original report, ZFTA:MAML2 fusion was frequent. Cluster 4 was enriched with sarcoma-like tumors. Moreover, we reported a novel anatomy of three ZFTA:NCOA1/2 fusions with only 1 ZFTA zinc finger domain in the putative fusion protein, whereas all previously reported non-RELA ZFTA fusions have 4 ZFTA zinc fingers. All three cases presented a sarcoma-like morphology. This genotype/phenotype association requires further studies for confirmation. Our series is the first to extensively characterize this new subset of supratentorial ZFTA-fused ependymomas and highlights the usefulness of ZFTA FISH analysis to confirm the existence of a rearrangement without RELA abnormality.

5 November 2020 in Acta Neuropathologica Communications
Verified
Journal Article
Open access
PDF file
CAC. Antin
C. Antin
ATA. Tauziède-Espariat
A. Tauziède-Espariat
MDM.-A. Debily
M.-A. Debily
DCD. Castel
D. Castel
JGJ. Grill
J. Grill
PVP. Varlet
P. Varlet

12 December 2022 in Histopathology
Verified
Journal Article
Open access
ATArnault Tauziède‐Espariat
Arnault Tauziède‐Espariat
MDMathilde Duchesne
Mathilde Duchesne
JBJessica Baud
Jessica Baud
MQMégane Le Quang
Mégane Le Quang
DBDorian Bochaton
Dorian Bochaton
FLFrancois le loarer
Francois le loarer
Aims: NTRK gene fusions have been described in a wide variety of central nervous system (CNS) and soft tissue tumours, including the provisional tumour type ‘spindle cell neoplasm, NTRK‐rearranged’ (SCN–NTRK), added to the 2020 World Health Organisation Classification of Soft Tissue Tumours. Because of histopathological and molecular overlaps with other soft tissue entities, controversy remains concerning the lineage and terminology of SCN–NTRK.Methods and results: This study included 16 mesenchymal tumours displaying kinase gene fusions (NTRK fusions and one MET fusion) initially diagnosed as infantile fibrosarcomas (IFS), SCN–NTRK and adult‐type fibrosarcomas from the soft tissue, viscera and CNS. We used immunohistochemistry, DNA methylation profiling, whole RNA‐sequencing and ultrastructural analysis to characterise them. Unsupervised t‐distributed stochastic neighbour embedding analysis showed that 11 cases (two CNS tumours and nine extra‐CNS) formed a unique and new methylation cluster, while all tumours but one, initially diagnosed as IFS, clustered in a distinct methylation class. All the tumours except one formed a single cluster within the hierarchical clustering of whole RNA‐sequencing data. Tumours from the novel methylation class co‐expressed CD34 and S100, had variable histopathological grades and frequently displayed a CDKN2A deletion. Ultrastructural analyses evidenced a myofibroblastic differentiation.Conclusions: Our findings confirm that SCN‐NTRK share similar features in adults and children and in all locations combine an infiltrative pattern, distinct epigenetic and transcriptomic profiles, and ultrastructural evidence of a myofibroblastic lineage. Further studies may support the use of new terminology to better describe their myofibroblastic nature.

9 July 2020 in Acta Neuropathologica Communications
Verified
Journal Article
Open access
PDF file
ATA. Tauziède-Espariat
A. Tauziède-Espariat
MDM-A Debily
M-A Debily
DCD. Castel
D. Castel
JGJ. Grill
J. Grill
SPS. Puget
S. Puget
PVP. Varlet
P. Varlet